New research has discovered a cell type that governs the way bones form and maintains themselves, opening up a potential target for future therapies for bone disorders like osteoporosis. Led by faculty from the Perelman School of Medicine at the University of Pennsylvania, a rodent study showed that bone marrow adipogenic lineage precursors (MALPs) play a distinct...
AMERICAN COLLEGE OF RHEUMATOLOGY Research NewsSHARE PRINT E-MAIL ATLANTA — A new study reveals that many older men who experience a fracture are still underdiagnosed with and undertreated for osteoporosis. Details of the study was presented at ACR Convergence, the American College Rheumatology’s annual meeting (ABSTRACT #0533). Osteoporosis is a common condition that results from a loss of...
IMIM (HOSPITAL DEL MAR MEDICAL RESEARCH INSTITUTE) Some of the principal treatments for osteoporosis, denosumab, zoledronate and calcium, could have a protective effect against COVID-19 in patients who take them, specifically a 30 to 40% reduction in the rate of infection, according to the results of a joint study by Hospital del Mar, the Hospital del Mar...
By Chloe Bennett, B.Sc. Reviewed by Emily Henderson, B.Sc. Osteoporosis is a significant public health concern that can adversely impair health-related quality of life. Approximately 10 million adults in America have the condition, with at least two million reported causes of new osteoporotic-related fractures occurring per year. What is Osteoporosis? Osteoporosis is a progressive skeletal...
Study finds calcium and vitamin d nutrient deficiencies lead to higher risk for osteoporosis in low income US population Pharmavite LLC, the makers of Nature Made vitamins, minerals and supplements, announced the publication of a research article in the journal PLoS ONE, which examines inadequate nutrient intake and its relationship to poor bone health, specifically...
Findings hold potential for cost savings while improving efficiency of screening HEBREW SENIORLIFE HINDA AND ARTHUR MARCUS INSTITUTE FOR AGING RESEARCH A new study shows that genetic pre-screening could reduce the number of screening tests needed to identify individuals at risk for osteoporotic fractures. Douglas P. Kiel, M.D., M.P.H.,director of the Musculoskeletal Research Center in...
Genomics carries great expectations: the power to help health-care providers assess and assist their patients in managing their individualized risks for common, serious medical conditions, such as cancer and heart disease. However, how to effectively meld genetic risk assessments into health care is a complex question. Several medical research institutions across the nation, including UW...
by Goldschmidt Conference In a novel collaboration, clinicians and geochemists have developed a test that can show the presence of osteoporosis before it has a noticeable clinical effect on bones. The methods are still being refined, but initial results show that it is more sensitive than the standard DXA osteoporosis scans, and can identify the...
Fewer vertebral fractures and fewer other typical fractures in postmenopausal women with severe osteoporosis at high risk of fracture INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE Romosozumab is a bone-forming monoclonal antibody used in women after menopause for the treatment of severe osteoporosis if there is a high risk of bone fractures. Having been...
Lack of proper nutrition education may affect female athletes’ performance and long-term health, says Rutgers researcher RUTGERS UNIVERSITY Two decades of research among female athletes over the age of 13 years shows that a lack of nutrition knowledge about what they need to eat to stay healthy and compete may contribute to poor performance, low...
